Stericycle Net Debt vs Non Current Liabilities Total Analysis
SRCL Stock | USD 61.98 0.51 0.83% |
Stericycle financial indicator trend analysis is much more than just breaking down Stericycle prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Stericycle is a good investment. Please check the relationship between Stericycle Net Debt and its Non Current Liabilities Total accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stericycle. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Stericycle Stock please use our How to buy in Stericycle Stock guide.
Net Debt vs Non Current Liabilities Total
Net Debt vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Stericycle Net Debt account and Non Current Liabilities Total. At this time, the significance of the direction appears to have totally related.
The correlation between Stericycle's Net Debt and Non Current Liabilities Total is 0.99. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Stericycle, assuming nothing else is changed. The correlation between historical values of Stericycle's Net Debt and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Stericycle are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Net Debt i.e., Stericycle's Net Debt and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.99 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Non Current Liabilities Total
Most indicators from Stericycle's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Stericycle current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stericycle. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Stericycle Stock please use our How to buy in Stericycle Stock guide.Tax Provision is expected to rise to about 26.4 M this year, although the value of Selling General Administrative will most likely fall to about 470.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 2.6B | 2.7B | 2.7B | 1.7B | Depreciation And Amortization | 223.9M | 232.5M | 216.5M | 227.3M |
Stericycle fundamental ratios Correlations
Click cells to compare fundamentals
Stericycle Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Stericycle fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.4B | 5.6B | 5.5B | 5.3B | 5.4B | 3.2B | |
Short Long Term Debt Total | 3.1B | 2.2B | 2.0B | 1.9B | 1.8B | 1.3B | |
Other Current Liab | 40.4M | 49.3M | 46.2M | (135M) | 307.3M | 322.7M | |
Total Current Liabilities | 756.9M | 697.1M | 731.7M | 621.9M | 718M | 753.9M | |
Total Stockholder Equity | 2.3B | 2.4B | 2.4B | 2.4B | 2.5B | 1.4B | |
Property Plant And Equipment Net | 1.2B | 1.1B | 1.1B | 1.1B | 1.2B | 1.2B | |
Net Debt | 3.1B | 2.1B | 1.9B | 1.9B | 1.7B | 1.3B | |
Retained Earnings | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B | 927.7M | |
Accounts Payable | 220.1M | 181.2M | 218.9M | 213.5M | 212.1M | 222.7M | |
Cash | 34.7M | 53.3M | 55.6M | 56M | 35.3M | 29.1M | |
Non Current Assets Total | 5.7B | 5.0B | 4.9B | 4.8B | 4.7B | 2.9B | |
Non Currrent Assets Other | 92.3M | 56.4M | 61.6M | (362.2M) | 82.5M | 86.6M | |
Cash And Short Term Investments | 34.7M | 53.3M | 55.6M | 56M | 35.3M | 30.2M | |
Net Receivables | 544.3M | 380.7M | 420.4M | 414.5M | 553.9M | 289.6M | |
Common Stock Shares Outstanding | 91M | 91.5M | 91.8M | 92.4M | 106.3M | 88.2M | |
Liabilities And Stockholders Equity | 6.4B | 5.6B | 5.5B | 5.3B | 5.4B | 3.2B | |
Non Current Liabilities Total | 3.3B | 2.5B | 2.3B | 2.3B | 2.1B | 1.5B | |
Inventory | 60.7M | 63M | 45.6M | 33.2M | 38.2M | 30.7M | |
Other Current Assets | 66.9M | 55.5M | 53.9M | 55M | 66.2M | 69.5M | |
Other Stockholder Equity | 1.2B | 1.2B | 1.3B | 1.3B | 1.3B | 1.4B | |
Total Liab | 4.1B | 3.1B | 3.1B | 2.9B | 2.8B | 1.9B | |
Total Current Assets | 706.6M | 552.5M | 575.5M | 558.7M | 655.4M | 384.9M | |
Short Term Debt | 199.8M | 177.2M | 107M | 116.4M | 126M | 75.3M | |
Intangible Assets | 1.4B | 1.1B | 964.5M | 811.1M | 686.5M | 729.1M | |
Property Plant And Equipment Gross | 1.2B | 1.1B | 1.7B | 1.8B | 1.8B | 1.9B | |
Accumulated Other Comprehensive Income | (318.1M) | (187.4M) | (218.8M) | (276.9M) | (184.5M) | (175.3M) | |
Other Liab | 430M | 462.3M | 469M | 474.7M | 545.9M | 573.2M | |
Other Assets | 92.3M | 422M | 61.6M | 64.8M | 74.5M | 53.2M | |
Long Term Debt | 2.6B | 1.7B | 1.6B | 1.5B | 1.3B | 1.4B | |
Good Will | 3.0B | 2.8B | 2.8B | 2.8B | 2.8B | 2.1B | |
Property Plant Equipment | 798.5M | 1.1B | 1.1B | 1.1B | 1.3B | 1.3B | |
Current Deferred Revenue | 296.6M | 289.4M | 359.6M | 427M | 72.6M | 96.1M | |
Net Tangible Assets | (2.1B) | (1.5B) | (1.4B) | (1.2B) | (1.4B) | (1.4B) | |
Noncontrolling Interest In Consolidated Entity | 9.7M | 3.8M | 4.3M | 4.1M | 3.9M | 3.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Stericycle. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Stericycle Stock please use our How to buy in Stericycle Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Environmental & Facilities Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stericycle. If investors know Stericycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stericycle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.167 | Earnings Share 0.39 | Revenue Per Share 28.384 | Quarterly Revenue Growth (0.01) | Return On Assets 0.023 |
The market value of Stericycle is measured differently than its book value, which is the value of Stericycle that is recorded on the company's balance sheet. Investors also form their own opinion of Stericycle's value that differs from its market value or its book value, called intrinsic value, which is Stericycle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stericycle's market value can be influenced by many factors that don't directly affect Stericycle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stericycle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stericycle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stericycle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.